Breastlink adopts iCAD's Xoft Axxent electronic brachytherapy system
Breastlink Medical Group has adopted iCAD's Xoft Axxent electronic brachytherapy system for breast cancer patients.
The Xoft system for intraoperative radiation therapy (IORT) delivers a single, prescribed, targeted dose of radiation during surgery directly to the tumor cavity, thus minimizing radiation to healthy tissue and organs.
The Xoft system can also be used for accelerated partial breast irradiation (APBI), which can be delivered twice daily for five days.
Breastlink Medical Group breast surgeon Amy Bremner said, "By adopting the Xoft system for IORT at our practice, we are providing select patients with a treatment option that lets them receive a full course of radiation therapy during their lumpectomy procedure, eliminating the emotional and physical burden of traditional radiation therapy which can require weeks of daily treatments."
iCAD said the Xoft system is cleared by the US Food and Drug Administration for the treatment of conditions where radiation is indicated, including early stage breast cancer, skin cancer and endometrial cancer.